Cytogen (Korea) Analysis

Cytogen Stock Analysis Notes

About 39.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Cytogen had 3:1 split on the 28th of September 2022. Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment and downstream systems to treat cancer in South Korea. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea. Cytogen is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Cytogen please contact the company at 82 2 6925 1070 or go to http://www.cytogenlab.com.

Cytogen Investment Alerts

Cytogen Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 95.89 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cytogen's market, we take the total number of its shares issued and multiply it by Cytogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 1st of December, Cytogen shows the Mean Deviation of 2.45, standard deviation of 3.19, and Risk Adjusted Performance of (0.01). Cytogen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cytogen Price Movement Analysis

Cytogen Outstanding Bonds

Cytogen Predictive Daily Indicators

Cytogen Forecast Models

Cytogen's time-series forecasting models are one of many Cytogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cytogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cytogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cytogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cytogen. By using and applying Cytogen Stock analysis, traders can create a robust methodology for identifying Cytogen entry and exit points for their positions.

When running Cytogen's price analysis, check to measure Cytogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytogen is operating at the current time. Most of Cytogen's value examination focuses on studying past and present price action to predict the probability of Cytogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytogen's price. Additionally, you may evaluate how the addition of Cytogen to your portfolios can decrease your overall portfolio volatility.